Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Johnson Einstein, M.D.

Concepts (134)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms92023108790.960 Why?
Terminal Care5201716490.750 Why?
Urogenital Neoplasms120201350.700 Why?
Receptors, Androgen3202310350.700 Why?
Androstenes220191690.690 Why?
Phenylurea Compounds120225280.680 Why?
Compassionate Use Trials12018460.670 Why?
Androgen Receptor Antagonists120191110.660 Why?
Quinolines120227230.610 Why?
Paternalism12016450.580 Why?
Carcinoma, Transitional Cell220217500.560 Why?
Death220176420.540 Why?
Telephone120196130.540 Why?
Advance Directives120162400.490 Why?
Empathy120184580.480 Why?
Personal Autonomy120162960.470 Why?
Physician-Patient Relations5202232250.470 Why?
Kidney Neoplasms2202241190.460 Why?
Carcinoma, Renal Cell3202330220.460 Why?
Cisplatin1201916220.450 Why?
Facial Paralysis120152960.420 Why?
Vascular Endothelial Growth Factor A2202234780.380 Why?
Urinary Bladder Neoplasms2202121150.370 Why?
Sarcoidosis120154960.370 Why?
Quality of Life22023121130.370 Why?
Neoplasm Recurrence, Local3202288960.350 Why?
Immunotherapy4202142570.340 Why?
CD8-Positive T-Lymphocytes2202143090.330 Why?
Internal Medicine1201510070.320 Why?
Cardiopulmonary Resuscitation120159360.310 Why?
Neoplasms62022209470.310 Why?
Internet1201930180.290 Why?
Palliative Care2202133590.280 Why?
Drug Resistance, Neoplasm1202051690.270 Why?
Medical Oncology1201721620.270 Why?
Decision Making2201638370.250 Why?
Prostatectomy3202318430.250 Why?
Radium12023540.220 Why?
Antineoplastic Agents32023135630.220 Why?
Receptor Tyrosine Kinase-like Orphan Receptors12022420.210 Why?
Thiohydantoins12021200.200 Why?
Phenylthiohydantoin220191900.200 Why?
Attitude of Health Personnel1201538370.200 Why?
Leuprolide120213120.170 Why?
Tumor Microenvironment2202133350.170 Why?
Receptors, Vascular Endothelial Growth Factor120226590.170 Why?
Humans3120237250010.170 Why?
Neutropenia120238790.160 Why?
Sickness Impact Profile120193080.160 Why?
Nitriles220199380.160 Why?
Morbidity1202317290.150 Why?
Benzamides2201913720.150 Why?
Urothelium120192780.150 Why?
Genes, Tumor Suppressor1202110920.140 Why?
Prednisone1202115510.140 Why?
Male1720233469640.140 Why?
Drug Approval120227340.140 Why?
Erythema Nodosum12015290.140 Why?
Lymphocytes, Tumor-Infiltrating1202110280.130 Why?
Internship and Residency1201556900.130 Why?
Serine120188220.130 Why?
Phylogeny1202127890.120 Why?
Soft Tissue Neoplasms1202313560.110 Why?
Renal Insufficiency120197850.110 Why?
Anecdotes as Topic12012570.110 Why?
Antineoplastic Agents, Hormonal1202115120.110 Why?
Angiogenesis Inhibitors1202220300.110 Why?
Androgen Antagonists1202013260.100 Why?
Sarcoma1202318880.100 Why?
Ambulatory Care Facilities120178980.100 Why?
Neoplasm Invasiveness1201936010.100 Why?
Professional-Patient Relations120167290.100 Why?
Hospice Care120176270.100 Why?
Xenograft Model Antitumor Assays1201835750.090 Why?
Prognosis32020287180.090 Why?
Biopsy1202167250.090 Why?
Survival Analysis22020102440.090 Why?
Virus Diseases120157030.090 Why?
Culture120126270.080 Why?
Molecular Targeted Therapy1201927590.080 Why?
Gene Expression Regulation, Neoplastic2202084530.080 Why?
Neovascularization, Pathologic1201726470.070 Why?
Risk Assessment42021231780.070 Why?
Prevalence12023149510.070 Why?
Cross-Sectional Studies22023240430.060 Why?
Neoplasm Staging12019109260.060 Why?
Phenotype12021162620.060 Why?
Clinical Trials as Topic1201978350.060 Why?
Longitudinal Studies12019136920.060 Why?
Aged620211613790.050 Why?
Antineoplastic Combined Chemotherapy Protocols22022113030.050 Why?
Age Factors12019183370.050 Why?
Kidney1201770220.050 Why?
United States22022684330.050 Why?
Autocrine Communication120221730.050 Why?
Role120201790.050 Why?
Diagnosis, Differential12015129370.050 Why?
RNA, Double-Stranded120212880.040 Why?
Middle Aged520212121550.040 Why?
Preoperative Period120215500.040 Why?
Combined Modality Therapy2202185770.040 Why?
Prospective Studies22021518530.040 Why?
Mice, Inbred ICR120183570.040 Why?
Physicians1201644460.040 Why?
Interferons120216870.040 Why?
Mitosis1202312460.040 Why?
beta Catenin1202210570.040 Why?
Salvage Therapy1202312500.040 Why?
Cohort Studies12019398830.040 Why?
Mutation12020296450.030 Why?
Epithelial-Mesenchymal Transition120206920.030 Why?
Androgens1202312480.030 Why?
Perception1202111710.030 Why?
Signal Transduction12017234450.030 Why?
Female320173753030.030 Why?
Mice, SCID1201827270.030 Why?
Prostate1202016790.030 Why?
Animals320231687350.030 Why?
Immunologic Factors1202115440.030 Why?
Prostate-Specific Antigen1202023520.020 Why?
Treatment Outcome32022616740.020 Why?
Drug Therapy, Combination1202164570.020 Why?
Neoadjuvant Therapy1202126180.020 Why?
Disease-Free Survival1202068810.020 Why?
Health Status Disparities1202017380.020 Why?
Patient Selection1202041960.020 Why?
Phosphorylation1201884920.020 Why?
Genomics1202055620.020 Why?
Immunohistochemistry12018114860.020 Why?
Cell Line, Tumor12018166340.010 Why?
Adult120152115230.010 Why?
Follow-Up Studies12020387200.010 Why?
Tomography, X-Ray Computed12020199030.010 Why?
Mice12023803180.010 Why?
Einstein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (134)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.